• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study.维生素 D 受体基因单倍型和多态性与乳腺癌风险:巢式病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1856-67. doi: 10.1158/1055-9965.EPI-12-0551. Epub 2012 Aug 14.
2
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.维生素D受体基因多态性、单倍型与绝经后乳腺癌风险
Breast Cancer Res. 2008;10(2):R31. doi: 10.1186/bcr1994. Epub 2008 Apr 17.
3
Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.北印度人群中维生素D受体基因多态性与乳腺癌风险
Cancer Detect Prev. 2009;32(5-6):386-94. doi: 10.1016/j.canep.2009.04.012.
4
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.维生素D受体基因多态性与乳腺癌风险:来自美国国立癌症研究所乳腺癌和前列腺癌队列联盟的结果。
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539.
5
Vitamin D receptor polymorphisms in patients with cutaneous melanoma.维生素 D 受体多态性与皮肤黑色素瘤。
Int J Cancer. 2012 Jan 15;130(2):405-18. doi: 10.1002/ijc.26023. Epub 2011 Apr 25.
6
Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.RANKL、OPG、CHI3L1 和 VDR 基因 SNP-SNP 相互作用与埃及女性乳腺癌风险的关联。
Clin Breast Cancer. 2019 Feb;19(1):e220-e238. doi: 10.1016/j.clbc.2018.09.004. Epub 2018 Sep 19.
7
Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.阐明PROGINS等位基因与卵巢癌和乳腺癌风险的关联:基于单倍型的分析。
J Natl Cancer Inst. 2005 Jan 5;97(1):51-9. doi: 10.1093/jnci/dji007.
8
Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers.常见维生素D受体变异与结肠癌和直肠癌的单倍型分析
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):744-9. doi: 10.1158/1055-9965.EPI-05-0814.
9
Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.维生素D受体多态性与食管维生素D受体表达降低及食管腺癌风险降低相关。
Mol Med. 2015 Apr 21;21(1):346-54. doi: 10.2119/molmed.2012.00336.
10
Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.维生素D受体基因BsmI多态性与乳腺癌风险的关联:一项巴基斯坦病例对照研究的结果
PLoS One. 2015 Oct 30;10(10):e0141562. doi: 10.1371/journal.pone.0141562. eCollection 2015.

引用本文的文献

1
The Relationship between Gene Polymorphisms and with Breast Cancer Risk.基因多态性与乳腺癌风险之间的关系。 (注:原英文表述有误,多了一个“with”,正确表述应该是The Relationship between Gene Polymorphisms and Breast Cancer Risk )
Glob Med Genet. 2024 Mar 4;11(1):69-75. doi: 10.1055/s-0044-1779040. eCollection 2024 Jan.
2
Assessment the effect of vitamin D supplementation on plasma vitamin D levels, inflammation, and oxidative stress biomarkers based on vitamin D receptor genetic variation in breast cancer survivors: a protocol for clinical trial.评估维生素 D 补充对乳腺癌幸存者血浆维生素 D 水平、炎症和氧化应激生物标志物的影响:一项临床试验方案,基于维生素 D 受体基因变异。
J Health Popul Nutr. 2021 Nov 2;40(1):46. doi: 10.1186/s41043-021-00272-9.
3
Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.维生素 D 受体基因变异与补充维生素 D3 的乳腺癌患者的癌症生物标志物:一项单臂非随机前后试验。
Nutrients. 2019 Jun 4;11(6):1264. doi: 10.3390/nu11061264.
4
Association of low penetrance vitamin D receptor Tru9I (rs757343) gene polymorphism with risk of premenopausal breast cancer.低外显率维生素D受体Tru9I(rs757343)基因多态性与绝经前乳腺癌风险的关联。
J Int Med Res. 2018 May;46(5):1801-1814. doi: 10.1177/0300060518761304. Epub 2018 Mar 12.
5
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway.维生素D受体多态性或血清水平是乳腺癌发展的关键驱动因素?维生素D途径问题。
Oncotarget. 2017 Feb 21;8(8):13142-13156. doi: 10.18632/oncotarget.14482.
6
Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis.维生素D受体多态性与乳腺癌风险:一项Meta分析。
Medicine (Baltimore). 2016 May;95(18):e3535. doi: 10.1097/MD.0000000000003535.
7
Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent.欧洲和东亚裔女性中维生素D相关基因的遗传变异与乳腺癌风险
Tumour Biol. 2016 May;37(5):6379-87. doi: 10.1007/s13277-015-4417-8. Epub 2015 Dec 2.
8
Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women.绝经后埃及女性中维生素D受体基因多态性与乳腺癌风险
Tumour Biol. 2015 Aug;36(8):6425-31. doi: 10.1007/s13277-015-3332-3. Epub 2015 Mar 25.
9
Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.巴基斯坦南部患者中维生素D受体Cdx-2基因多态性与绝经前乳腺癌风险
PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015.
10
Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.维生素D受体与癌症风险的荟萃分析:聚焦于TaqI、ApaI和Cdx2基因多态性的作用
Eur J Cancer Prev. 2016 Jan;25(1):85-96. doi: 10.1097/CEJ.0000000000000132.

本文引用的文献

1
Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.血清 25-羟维生素 D 与乳腺癌风险:一项基于墨西哥女性的大型人群病例对照研究结果。
Cancer Causes Control. 2012 Jul;23(7):1149-62. doi: 10.1007/s10552-012-9984-z. Epub 2012 May 24.
2
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.美国西南部女性的维生素 D 摄入、维生素 D 受体多态性与乳腺癌风险
Breast Cancer Res Treat. 2012 Apr;132(2):683-91. doi: 10.1007/s10549-011-1885-4. Epub 2011 Dec 1.
3
Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario.安大略省的白人女性中维生素 D 相关遗传变异、维生素 D 暴露与乳腺癌风险的关系。
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1708-17. doi: 10.1158/1055-9965.EPI-11-0300. Epub 2011 Jun 21.
4
Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women.青春期和成年期暴露于紫外线阳光下与乳腺癌风险:安大略省女性的基于人群的病例对照研究。
Am J Epidemiol. 2011 Aug 1;174(3):293-304. doi: 10.1093/aje/kwr091. Epub 2011 Jun 9.
5
Prospective study of UV exposure and cancer incidence among Swedish women.瑞典女性的紫外线暴露与癌症发病率前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1358-67. doi: 10.1158/1055-9965.EPI-11-0071. Epub 2011 May 6.
6
An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production.一项关于法国癌症发病率和死亡率与纬度(维生素D生成指标)关系的生态学研究。
Dermatoendocrinol. 2010 Apr;2(2):62-7. doi: 10.4161/derm.2.2.13624.
7
Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study.主动和被动吸烟与绝经后妇女乳腺癌风险的关联:一项前瞻性队列研究。
BMJ. 2011 Mar 1;342:d1016. doi: 10.1136/bmj.d1016.
8
Cigarette smoking and the incidence of breast cancer.吸烟与乳腺癌发病率
Arch Intern Med. 2011 Jan 24;171(2):125-33. doi: 10.1001/archinternmed.2010.503.
9
Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).主动吸烟和二手烟会增加乳腺癌风险:加拿大烟草烟雾与乳腺癌风险专家组报告(2009 年)。
Tob Control. 2011 Jan;20(1):e2. doi: 10.1136/tc.2010.035931. Epub 2010 Dec 8.
10
Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort.膳食维生素 D 和阳光暴露对乳腺癌风险的联合影响:来自法国 E3N 队列的研究结果。
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):187-98. doi: 10.1158/1055-9965.EPI-10-1039. Epub 2010 Dec 2.

维生素 D 受体基因单倍型和多态性与乳腺癌风险:巢式病例对照研究。

Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study.

机构信息

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1856-67. doi: 10.1158/1055-9965.EPI-12-0551. Epub 2012 Aug 14.

DOI:10.1158/1055-9965.EPI-12-0551
PMID:22892281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3483029/
Abstract

BACKGROUND

Observational and experimental studies suggest that vitamin D may influence breast cancer etiology. Most known effects of vitamin D are mediated via the vitamin D receptor (VDR). Few polymorphisms in the VDR gene have been well studied in relation to breast cancer risk and results have been inconsistent.

METHODS

We investigated VDR polymorphisms and haplotypes in relation to breast cancer risk by genotyping 26 single nucleotide polymorphisms (SNP) that (i) had known/suspected impact on VDR function, (ii) were tagging SNPs for the three VDR haplotype blocks among whites, or (iii) were previously associated with breast cancer risk. We estimated odds ratios (OR) and 95% confidence intervals (CI) in relation to breast cancer risk among 270 incident cases and 554 matched controls within the Agricultural Health Study cohort.

RESULTS

In individual SNP analyses, homozygous carriers of the minor allele for rs2544038 had significantly increased breast cancer risk (OR = 1.5; 95% CI: 1.0-2.5) and homozygous carriers of the minor allele for rs11168287 had significantly decreased risk (OR = 0.6; 95% CI: 0.4-1.0). Carriers of the minor allele for rs2239181 exhibited marginally significant association with risk (OR = 1.4; 95% CI: 0.9-2.0). Haplotype analyses revealed three haplotype groups (blocks "A," "B," and "C"). Haplotype GTCATTTCCTA in block B was significantly associated with reduced risk (OR = 0.5; 95% CI: 0.3-0.9).

CONCLUSIONS

These results suggest that variation in VDR may be associated with breast cancer risk.

IMPACT

Our findings may help guide future research needed to define the role of vitamin D in breast cancer prevention.

摘要

背景

观察性和实验研究表明,维生素 D 可能影响乳腺癌的病因。维生素 D 的大多数已知作用是通过维生素 D 受体 (VDR) 介导的。VDR 基因中的少数多态性与乳腺癌风险的关系已经得到了很好的研究,但结果并不一致。

方法

我们通过对 26 个单核苷酸多态性 (SNP) 进行基因分型,研究了 VDR 多态性和单倍型与乳腺癌风险的关系,这些 SNP (i)对 VDR 功能有已知/疑似影响,(ii)是白人三个 VDR 单倍型块的标记 SNP,或(iii)先前与乳腺癌风险相关。我们在农业健康研究队列中,对 270 例新发病例和 554 例匹配对照进行了与乳腺癌风险相关的比值比 (OR) 和 95%置信区间 (CI) 的估计。

结果

在个体 SNP 分析中,rs2544038 中的次要等位基因纯合子携带者的乳腺癌风险显著增加(OR = 1.5;95%CI:1.0-2.5),rs11168287 中的次要等位基因纯合子携带者的乳腺癌风险显著降低(OR = 0.6;95%CI:0.4-1.0)。rs2239181 的次要等位基因携带者与风险呈边缘显著相关(OR = 1.4;95%CI:0.9-2.0)。单倍型分析显示出三个单倍型组(块“A”、“B”和“C”)。块 B 中的 GTCATTTCCTA 单倍型与风险降低显著相关(OR = 0.5;95%CI:0.3-0.9)。

结论

这些结果表明,VDR 的变异可能与乳腺癌风险相关。

影响

我们的发现可能有助于指导未来需要定义维生素 D 在乳腺癌预防中的作用的研究。